Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVPOME vs POM in Subjects Requiring Additional Keratinized Oral Mucosa for Dental Implants
NCT01834326Phase 2Terminated
- Start
- Apr 2014
- Primary completion
- Jan 2019
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of EVPOME. Started Apr 2014; status: terminated.
02
Drugs
EVPOME
Beyond the preview
Go deeper on NCT01834326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01834326.